ClinicalTrials.Veeva

Menu

Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Meconium Obstruction of Prematurity

Study type

Observational

Funder types

Other

Identifiers

NCT02864446
1208-071-422

Details and patient eligibility

About

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.

Enrollment

100 patients

Sex

All

Ages

Under 36 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • preterm infants weighing <1,250g

Exclusion criteria

  • major congenital anomalies
  • perinatal asphyxia (cord pH <7.0)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems